Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PHIO - Phio Pharma rises 11% on positive data from preclinical study of PH-762 to treat melanoma

PHIO - Phio Pharma rises 11% on positive data from preclinical study of PH-762 to treat melanoma

Phio Pharmaceuticals Corp.

2023-04-17 11:02:23 ET

  • Phio Pharmaceuticals ( NASDAQ: PHIO ) is trading ~11% higher after it said a preclinical study showed that intratumoral administration of its drug, mPH-762, stimulated a local anti-tumor immune response and generated systemic tumor-reactive memory T cells in mouse model.
  • "These preclinical study results support intratumoral use of PH-762 in the clinical setting, with deeper understanding of the mechanism of abscopal efficacy," the company said.
  • PH-762 is undergoing clinical development in a phase 1b trial for neoadjuvant treatment specifically designed for advanced resectable melanoma.
  • Press Release

For further details see:

Phio Pharma rises 11% on positive data from preclinical study of PH-762 to treat melanoma
Stock Information
Company Name: Phio Pharmaceuticals Corp.
Stock Symbol: PHIO
Market: NASDAQ
Website: phiopharma.com
Menu
PHIO PHIO Quote PHIO Short PHIO News PHIO Articles PHIO Message Board
Get PHIO Alerts

News, Short Squeeze, Breakout and More Instantly...